Jonathan Wosen, Ph.D.

West Coast Biotech & Life Sciences Reporter for @statnews. Formerly with @sdut. @Stanford Immunology PhD & @UCSC_SciCom alum. Tips? [email protected]

[Jonathan Wosen, Ph.D. @JonathanWosen]

Hey folks! A friendly note that you can find me on Bluesky (@jonathanwosen.bsky.social). I'll for now continue to post here on X, but that may wind down with time. I also routinely share stories via LinkedIn: https://t.co/Up3Oz7PLRr

[Helen Branswell 🇨🇦 @HelenBranswell]

#CDC has been without a director for most of Trump 2.0. A new nominee was put forward today, Erika Schwartz, a former deputy surgeon general. (Nomination was scooped earlier this week by @ddiamond & @bylenasun ).
Let's see what happens. https://t.co/XSmgejRWyd

[STAT @statnews]

Biotech legend Stelios Papadopoulos on the state of the Food and Drug Administration: "If the FDA were a company, you know what would happen? Everybody would be shorting the stock."
#STATBreakthrough

[Helen Branswell 🇨🇦 @HelenBranswell]

Multiple vaccines offer benefits beyond protecting the vaccinated individual from the disease the vaccine targets. Some protect fetuses in the womb, some protect people who are immunocompromised, some protect seniors. As vax rates fall, these benefits are threatened. https://t.co/zmiws8gAnw

[Matthew Herper @matthewherper]

Katrine Bosley: There's no question “hopes and aspirations” got ahead of the pace of any new science on gene editing #STATBreakthrough

Seng Cheng: “The promise of gene therapy is correct. I think it has made that promise. and that's demonstrated by the few and grueling approvals that we've seen that are truly transformative for our patients.”

$AZN

[Jonathan Wosen, Ph.D. @JonathanWosen]

@aclong111 @statnews @jaspar That's a good point. For our story, I spoke with a Case Western researcher who lost a $400,000 grant and later got $10,000 from a foundation to keep the project limping along. And private funders don't provide as much support for research overhead as NIH.

[Jonathan Wosen, Ph.D. @JonathanWosen]

One of many, many jarring statistics from our @statnews survey of NIH-funded researchers: Among scientists who'd sought outside money to fill funding gaps, 63% said they didn't get enough support to sustain their work. Chart by @jaspar

[Jonathan Wosen, Ph.D. @JonathanWosen]

@statnews conducted a national survey of NIH-funded researchers and found that, a year after Trump's return, many scientists are reeling, with some closing labs entirely. ‘This is like the Titanic,' one respondent told me. For full details, see our story
https://t.co/2SlWv4jfWj

[Jake Scott, MD @jakescottMD]

Vaccines don't just protect the person who receives them. @HelenBranswell does brilliant work breaking down the knock-on benefits we've quietly taken for granted and stand to lose. @statnews
https://t.co/CPDUJz4UCC

[Jonathan Wosen, Ph.D. @JonathanWosen]

Interviews with 30 researchers who responded to a nationwide @statnews survey on the impacts of federal science policy brought the human toll of changes at NIH into sharp focus. @AnilOza16 and I bring you 3 of those stories. 👇
https://t.co/OIH0FoNrsm

[Jonathan Wosen, Ph.D. @JonathanWosen]

@statnews conducted a national survey of NIH-funded researchers and found that, a year after Trump's return, many scientists are reeling, with some closing labs entirely. ‘This is like the Titanic,' one respondent told me. For full details, see our story
https://t.co/2SlWv4jfWj

[Lizzy Lawrence @LizzyLaw_]

Very excited to interview former FDA commissioner Rob Califf about the recent turmoil at FDA, from leadership upheaval to politicization of science, at STAT's Breakthrough Summit East in NYC on Thursday. You can register for tickets here: https://t.co/qjWpN5QEoy #STATBreakthrough

[Jonathan Wosen, Ph.D. @JonathanWosen]

NIH Director Jay Bhattacharya promised a House Appropriations subcommittee on Tuesday that, despite the sluggish pace of grant awards, the agency will spend its full budget by the end of the 2026 fiscal year. My latest for @statnews
https://t.co/Oq2nGrs6UY

[STAT @statnews]

Win a free virtual pass to STAT’s Breakthrough East summit this Thursday!

How to enter:

✅Repost this post
✅ In your repost, share what you’re excited to learn (science, medicine, biotech, policy, etc.)
✅Add #STATBreakthrough
That's it!

https://t.co/SZadDDZ4dR

[Rick Berke @rickberke]

As Bhattacharya prepares to testify on Hill, analysis shows NIH grants are lagging far behind historical averages, reports ⁦@AnilOza16⁩ https://t.co/mCUZcq8kOY

[Rick Berke @rickberke]

Big news at ⁦@statnews⁩: Welcoming Seth Harris as our first SVP to lead our business into a second decade! https://t.co/FJOvXDYSzm

[Lizzy Lawrence @LizzyLaw_]

BREAKING: Vinay Prasad is leaving the FDA for the second time. First reported by @l_e_whyte:
https://t.co/x1yPG7VG7Y

[STAT @statnews]

It's time to VOTE!
#STATMadness is back! Our bracket-style contest to find the best innovation in science and medicine.
Help us crown a new champ! Vote now: https://t.co/GncreYUf1g

[Jonathan Wosen, Ph.D. @JonathanWosen]

A rare disease drug was approvable, then it wasn’t. Inside a surprise rejection by the FDA. Excellent reporting by @adamfeuerstein in this @statnews exclusive https://t.co/OzYTcBlb1r

[Jonathan Wosen, Ph.D. @JonathanWosen]

A key U.K. study of Grail’s multi-cancer detection test has failed, a major setback for the company,
@matthewherper writes for @statnews
https://t.co/IdB3zNbHMt

[STAT @statnews]

#Breaking: Jay Bhattacharya will take on leadership of the CDC. He's the third leader of the public health agency since this summer. https://t.co/6tpg2RQeOp

[Jonathan Cohn @CitizenCohn]

FDA reversing itself on the Moderna shot is better than the alternative, but this saga is still a sign of chaos at the agency -- and, now, in the vaccine pipeline

A (typically) smart and must-read analysis from @matthewherper https://t.co/9NdVl0OK0K